Back

REST-AKT-SOX2 axis controls neuronal lineage state and Midkine-mediated communication in SHH-medulloblastoma.

Singh, A.; Guo, L.; Swaminathan, J.; Cheng, D.; Yang, Y.; Manickavinayaham, S.; Xu, L.; Gopalakrishnan, V.

2026-04-09 cancer biology
10.64898/2026.04.06.716597 bioRxiv
Show abstract

Stem/progenitor-like cells are known drivers of tumor progression, chemoresistance, and relapse in Sonic-Hedgehog medulloblastoma (SHH-MB), yet the regulatory mechanisms that sustain these resilient cellular states remain incompletely defined. Here, we identify the RE1-silencing transcription factor (REST) as a key transcriptional regulator that preserves the progenitor compartment in SHH-MB through stabilization of the stemness factor SOX2. Mechanistically, REST activates AKT signaling, which in turn enhances SOX2 protein stability, revealing a REST-AKT-SOX2 axis that supports stem/progenitor identity and ongoing tumor maintenance. Beyond maintaining intrinsic stem-like programs, REST also orchestrates the extrinsic communication network of SHH-MB tumors. Single cell transcriptomic profiling and ligand-receptor interaction mapping highlight Midkine (MDK)-mediated signaling as one of the most upregulated intercellular communication routes in MB. We demonstrate that REST drives this signaling cascade through its control of SOX2. Perturbation of REST or SOX2 results in reduced MDK and its receptor, SDC2 expression, and chromatin immunoprecipitation assays show that SOX2 directly binds and regulates MDK/SDC2 expression, establishing and reinforcing a REST/SOX2 centered transcriptional mechanism that coordinates both progenitor maintenance and cell-cell communication in the malignant compartment. Together, these findings position REST as an integrator of intrinsic progenitor cell programs and extrinsic MDK-mediated signaling in SHH-MB. By linking stemness, communication and potential for therapeutic resistance, the REST-AKT-SOX2-MDK signaling axis emerges as a targetable vulnerability to suppress stem/progenitor driven tumor program in REST-driven SHH-MBs.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Molecular Cell
308 papers in training set
Top 0.5%
18.4%
2
Nature Communications
4913 papers in training set
Top 17%
10.3%
3
Nature
575 papers in training set
Top 3%
9.0%
4
Cancer Discovery
61 papers in training set
Top 0.1%
8.3%
5
Cell Reports
1338 papers in training set
Top 4%
8.3%
50% of probability mass above
6
Science
429 papers in training set
Top 7%
4.3%
7
Developmental Cell
168 papers in training set
Top 5%
3.6%
8
Cell Stem Cell
57 papers in training set
Top 0.7%
2.7%
9
Nature Genetics
240 papers in training set
Top 3%
2.4%
10
Nature Cancer
35 papers in training set
Top 0.5%
2.1%
11
Nature Cell Biology
99 papers in training set
Top 2%
1.9%
12
Science Advances
1098 papers in training set
Top 15%
1.9%
13
eLife
5422 papers in training set
Top 43%
1.7%
14
Cancer Cell
38 papers in training set
Top 1.0%
1.7%
15
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.7%
16
Cancer Research
116 papers in training set
Top 2%
1.5%
17
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.3%
18
Cell
370 papers in training set
Top 13%
1.3%
19
Genes & Development
90 papers in training set
Top 0.6%
1.3%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 38%
1.2%
21
Cell Genomics
162 papers in training set
Top 5%
0.9%
22
Science Translational Medicine
111 papers in training set
Top 5%
0.9%
23
Immunity
58 papers in training set
Top 4%
0.9%
24
Nature Chemical Biology
104 papers in training set
Top 4%
0.7%
25
Oncogene
76 papers in training set
Top 2%
0.6%
26
Cell Reports Medicine
140 papers in training set
Top 9%
0.6%